CUMBERLAND PHARMACEUTICALS INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cumberland Pharmaceuticals Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Cumberland Pharmaceuticals Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $21.9M, a 1.45% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $21.9M +$312K +1.45% Dec 31, 2023 10-K 2024-03-13
Q4 2022 $21.6M +$1.8M +9.09% Dec 31, 2022 10-K 2024-03-13
Q4 2021 $19.8M +$566K +2.95% Dec 31, 2021 10-K 2023-03-13
Q4 2020 $19.2M +$685K +3.7% Dec 31, 2020 10-K 2022-03-11
Q4 2019 $18.5M +$1.13M +6.5% Dec 31, 2019 10-K 2021-03-12
Q4 2018 $17.4M +$1.75M +11.2% Dec 31, 2018 8-K 2020-12-10
Q1 2018 $15.9M $0 0% Mar 31, 2018 10-K 2019-03-12
Q4 2017 $15.6M +$15.2M +3924% Dec 31, 2017 10-K 2019-03-12
Q3 2017 $15.9M Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $15.9M Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $15.9M Mar 31, 2017 10-K 2018-03-09
Q4 2016 $389K +$203K +109% Dec 31, 2016 10-K 2018-03-09
Q4 2015 $185K +$33.4K +22% Dec 31, 2015 10-K 2017-03-13
Q4 2014 $152K +$20.5K +15.5% Dec 31, 2014 10-K 2016-03-14
Q4 2013 $132K +$23.3K +21.5% Dec 31, 2013 10-K 2015-03-09
Q4 2012 $108K +$13.9K +14.7% Dec 31, 2012 10-K 2014-03-11
Q4 2011 $94.5K Dec 31, 2011 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.